VIRACEPT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Viracept, and what generic alternatives are available?
Viracept is a drug marketed by Agouron Pharms and is included in three NDAs.
The generic ingredient in VIRACEPT is nelfinavir mesylate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nelfinavir mesylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIRACEPT?
- What are the global sales for VIRACEPT?
- What is Average Wholesale Price for VIRACEPT?
Summary for VIRACEPT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 43 |
Patent Applications: | 4,881 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VIRACEPT |
What excipients (inactive ingredients) are in VIRACEPT? | VIRACEPT excipients list |
DailyMed Link: | VIRACEPT at DailyMed |
![VIRACEPT drug patent expirations Drug patent expirations by year for VIRACEPT](/p/graph/s/t/VIRACEPT-patent-expirations.png)
![Drug Prices for VIRACEPT](/p/graph/drug-price/VIRACEPT.png)
Recent Clinical Trials for VIRACEPT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 1 |
Joseph Anthony Lucci III | Phase 2 |
The University of Texas Health Science Center, Houston | Phase 2 |
Pharmacology for VIRACEPT
Drug Class | Protease Inhibitor |
Mechanism of Action | Cytochrome P450 3A Inhibitors HIV Protease Inhibitors |
US Patents and Regulatory Information for VIRACEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIRACEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIRACEPT
See the table below for patents covering VIRACEPT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | 0900219 | ⤷ Sign Up | |
Malaysia | 138860 | HIV PROTEASE INHIBITORS. | ⤷ Sign Up |
Denmark | 0722439 | ⤷ Sign Up | |
New Zealand | 275633 | N-(3-HETERO)CYCLYL-2-HYDROXY PROPYL)-(HETERO)CYCLYL CARBOXAMIDE DERIVATIVES AND ANALOGUES | ⤷ Sign Up |
Singapore | 49247 | Hiv protease inhibitors | ⤷ Sign Up |
China | 1262272 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |